戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  research, and positron emission tomographic vascular imaging.
2 hy and FCA among those subjects who received vascular imaging.
3 blood perfusion was reduced as documented by vascular imaging.
4 d specific educational components of CMR and vascular imaging.
5 use formal educational curricula for CMR and vascular imaging.
6 cell arteritis is most commonly diagnosed by vascular imaging.
7 ed the diagnostic and therapeutic aspects of vascular imaging.
8 ve the quality, workflow, and reliability of vascular imaging.
9 nt recently used for magnetic resonance (MR) vascular imaging.
10  significant improvements in many aspects of vascular imaging.
11 nical developments in cardiac, thoracic, and vascular imaging.
12                           Most favorably for vascular imaging, [(18)F]5j exhibited low uptake in meta
13  Of 1368 eligible patients with intracranial vascular imaging, 241 (17.6%) had 385 50-99% symptomatic
14 ith tumors in host animals injected with the vascular imaging agent gadolinium also being enhanced le
15  Emerging evidence based on ultrasonographic vascular imaging and angiogenic biomarkers implicates an
16 management strategies were evaluated: (a) no vascular imaging and best medical management, (b) CT ang
17 d registry of patients with FMD confirmed by vascular imaging and currently enrolling at 14 participa
18 isplays favorable pharmacokinetics for early vascular imaging and enables specific detection of infla
19 a, Europe, and the USA, with early brain and vascular imaging and follow up.
20  has routinely involved punch skin biopsies, vascular imaging and graft appearance.
21     With ongoing advancements in noninvasive vascular imaging and high-throughput genomics, we have t
22 us contrast enhancement dramatically improve vascular imaging and resolution within the prostate.
23  the current training environment in CMR and vascular imaging and the recommendations of COCATS-2.
24  cardiovascular magnetic resonance (CMR) and vascular imaging and to quantify the magnitude of any ga
25 timodality imaging technology, molecular and vascular imaging, and clinical guidelines with appropria
26 hy, EF5 immunostaining, Hoechst fluorescence vascular imaging, and hematoxylin-and-eosin histology-we
27 ates some predictive value for hypertension, vascular imaging, and polymorphisms affecting components
28                                 This in vivo vascular imaging approach is valuable in monitoring norm
29 selection criteria, use of optimal brain and vascular imaging, appropriate devices for recanalization
30 ve imaging and clinical education, including vascular imaging as well as cardiac.
31  care networks, the question of the need for vascular imaging at the RHs remains unsolved, resulting
32 fits in reduction of delay before treatment, vascular imaging-based triage of patients with large-ves
33 CTA) is widely used for non-invasive retinal vascular imaging, but the OCTA methods used to assess re
34                Use of iodinated contrast for vascular imaging can be associated with nephrotoxicity a
35                                              Vascular imaging can be challenging because of the wide
36                  Despite frequently observed vascular imaging changes in individuals with TBI, the re
37 hagic manifestations were also observed, but vascular imaging did not demonstrate overt abnormalities
38 atheter manipulation, as well as specialized vascular imaging equipment.
39                      We focused on four main vascular imaging features and risk factors: microbleeds;
40 e (>1200 nm) enables high-resolution in vivo vascular imaging, further enhanced by AI-driven imaging
41                                           No vascular imaging had the highest cost and lowest health
42      The advancements that have been made in vascular imaging have enabled improvement in diagnosis a
43 ained renal ECM scaffolds were processed for vascular imaging, histology, and cell seeding to investi
44 hy followed by immediate thrombectomy and no vascular imaging in 55-year-old patients compared with $
45 iew explores the current uses of noninvasive vascular imaging in LVV.
46 otential use for CO2 as a contrast agent for vascular imaging in patients with suboptimal renal funct
47                                    Emergency vascular imaging, including arteriography and venography
48 r findings suggest that in certain subgroups vascular imaging, including collateral assessment, can p
49                                 In addition, vascular imaging is also crucial for longitudinal survei
50 es when more detailed three-dimensional (3D) vascular imaging is required, or when ultrasound windows
51                                              Vascular imaging makes it possible to quantify the numbe
52 isk plaque in vivo; however, these important vascular imaging methods additionally promise great scie
53                                 Non-invasive vascular imaging methods that could be used to identify
54                         Therefore, different vascular imaging modalities are used in management of su
55  of molecular probes for alternative in vivo vascular imaging modalities, but few options for genetic
56 ence tomography angiography is a noninvasive vascular imaging modality that clearly depicts the loopi
57 M revealed high contrast and high resolution vascular imaging of the retina and choroid with amplifie
58  a prospective cohort evaluating the role of vascular imaging on cardiovascular risk prediction.
59 ptimal renal function who require definitive vascular imaging or therapy.
60 eld MSOT was found to be capable of clinical vascular imaging, providing visualization of major blood
61                      In this work, providing vascular imaging results did not improve diet but did im
62 ted large-vessel occlusion in the absence of vascular imaging results in worse health outcomes and hi
63                    Provision of non-invasive vascular imaging results to individuals has been shown t
64               Of 667 subjects, 525 had known vascular imaging results, and 53% of those (n=277) had a
65  label-free, high resolution, and wide-field vascular imaging, revealed the absence of both capillary
66                                              Vascular imaging should be mandated in future endovascul
67 troke-specialist assessment, urgent MRI, and vascular imaging should now be considered, with monitori
68 Early CT Score (ASPECTS) greater than 4, and vascular imaging showing moderate-to-good collateral fil
69                                 Superb micro-vascular imaging (SMI) was used as an MVUS technique in
70 al animal studies, human biomarker data, and vascular imaging studies provide support for proceeding
71         Whether carotid ultrasound and other vascular imaging studies should be performed routinely f
72                                              Vascular imaging studies were performed at least yearly
73 e. punch skin biopsies, DSA and conventional vascular imaging studies) are inadequate for detecting t
74 utcome was receipt of a vascular assessment (vascular imaging study or revascularization procedure) i
75 isk factor assessment, as well as a complete vascular imaging study that was performed blinded to the
76             Electrophysiological studies and vascular imaging suggest an ON-limited infarct with subs
77 ing whole brain CT perfusion and concomitant vascular imaging, suggest that age has a differential ef
78 essible alternatives to expensive commercial vascular imaging systems by providing comprehensive tool
79 disease activity is challenging, progress in vascular imaging techniques and the measurement of labor
80                                 Conventional vascular imaging techniques for analysis of intracranial
81 to the widespread use of noninvasive in vivo vascular imaging techniques is the current lack of suita
82               Magnetic resonance imaging and vascular imaging techniques play a critical role in iden
83                                    Real-time vascular imaging that provides both anatomic and hemodyn
84    After a review of basic considerations in vascular imaging, the established methods for nonenhance
85 /MRI, Cardiac MRI, Congenital Heart Disease, Vascular Imaging, Thoracic Imaging, Artificial Intellige
86 /MRI, cardiac MRI, congenital heart disease, vascular imaging, thoracic imaging, artificial intellige
87 imaging platforms are available for targeted vascular imaging to acquire information on both anatomy
88 vity DNA sequencing in blood and noninvasive vascular imaging to investigate the interplay between cl
89 gy applications, including material science, vascular imaging, vaccine development, and targeted drug
90                                              Vascular imaging was not a requirement in the trials.
91                               By fluorescent vascular imaging, we provide evidence that the vasculatu
92 ithout stenting, and those with intracranial vascular imaging were analysed in our study, which asses
93      Histological, immunofluorescent, and 3D vascular imaging were used to evaluate glomerular, tubul
94 ed breast MRI, and it may increase access to vascular imaging while reducing examination cost.
95                                              Vascular imaging with color and power Doppler is a usefu
96  multimodality pipeline that enables ex vivo vascular imaging with magnetic resonance imaging, comput
97                                      Retinal vascular imaging with pvOCT provides accurate measuremen
98 ultaneous electrophysiological recording and vascular imaging with transcriptomic analysis in rats, a